Skip to main content

An experimental drug protects Covid-19 patients, Eli Lilly claims

By The New York Times  
   September 16, 2020

A so-called monoclonal antibody lowered blood levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts.

Full story

Get the latest on healthcare leadership in your inbox.